Jonathan Gertler, Back Bay Life Science Advisors CEO

Back Bay makes deal with Nor­way's DNB in bank­ing and ad­vi­so­ry part­ner­ship

The Nor­we­gian in­vest­ment bank DNB will take a “mean­ing­ful mi­nor­i­ty stake” in Back Bay Life Sci­ence Ad­vi­sors in a part­ner­ship that Back Bay says will help both com­pa­nies ex­pand their of­fer­ings to biotech and phar­ma.

Back Bay of­fers ad­vi­so­ry and in­vest­ment bank­ing ser­vices, and the part­ner­ship will help it get in­volved in big­ger trans­ac­tions that the bou­tique firm might have pre­vi­ous­ly seen pass on to oth­er ad­vi­sors. The com­pa­ny, which has about 30 staffers, is based in Boston and has been in­volved in a long list of li­cens­ing and pipeline deals.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.